CoChat

Interleukin‐13 promoter gene polymorphism ‐1112C/T is associated with the systemic form of mastocytosis

Nedoszytko, B., Niedoszytko, M., Lange, M., Van Doormaal, J., Gleń, J., Zabłotna, M., Renke, J., Vales, A., Buljubasic, F., Jassem, E., Roszkiewicz, J., Valent, P. · 2009 · Allergy
Cited by 35

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Mastocytosis is a heterogenous disease involving mast cells (MC) and their progenitors. Cutaneous and systemic variants of the disease have been reported. In contrast to cutaneous mastocytosis (CM), patients with systemic mastocytosis (SM) are at risk to develop disease progression or a nonMC‐lineage haematopoietic neoplasm. Little is known, however, about factors predisposing for the development of SM. One factor may be cytokine regulation of MC progenitors. Methods: We examined the role of the interleukin‐13 (IL‐13) promoter gene polymorphism ‐1112C/T, known to be associated with increased transcription, in mastocytosis using allele‐specific polymerase chain reaction method. Serum tryptase and IL‐13 levels were determined by immunoassay, and expression of the IL‐13 receptor in neoplastic MC by reverse transcription‐polymerase chain reaction and flow cytometry. Results: The frequency of the ‐1112T allele of the IL‐13 promoter was significantly higher in patients with SM compared with CM (P < 0.008) and in mastocytosis patients compared with healthy controls (P < 0.0001). Correspondingly, the polymorphism was found to correlate with an elevated serum tryptase level (P = 0.004) and with adult‐onset of the disease (P < 0.0015), both of which are almost invariably associated with SM. Serum IL‐13 levels were also higher in SM patients compared with CM (P = 0.011), and higher in CT‐ than in CC carriers (P < 0.05). Finally, we were able to show that neoplastic human MC display IL‐13 receptors and grow better in IL‐13‐containing medium. Conclusions: The ‐1112C/T IL‐13 gene polymorphism and the resulting ‘hypertranscription’ may predispose for the development of SM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1398-9995.2008.01827.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 35

Metadata

Authors
Nedoszytko, B., Niedoszytko, M., Lange, M., Van Doormaal, J., Gleń, J., Zabłotna, M., Renke, J., Vales, A., Buljubasic, F., Jassem, E., Roszkiewicz, J., & Valent, P.
Venue
Allergy
Publisher
Wiley
Published
2009-01-21
Volume
64
Issue
2
Pages
287-294
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2144267170
Cited by
35
References
6
FWCI
1.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin‐13 promoter gene polymorphism ‐1112C/T is associated with the systemic form of mastocytosis. https://app.cochat.ai/papers/10.1111/j.1398-9995.2008.01827.x
The paper
Nedoszytko, B., Niedoszytko, M., Lange, M., Van Doormaal, J., Gleń, J., Zabłotna, M., Renke, J., Vales, A., Buljubasic, F., Jassem, E., Roszkiewicz, J., & Valent, P. (2009). Interleukin‐13 promoter gene polymorphism ‐1112C/T is associated with the systemic form of mastocytosis. Allergy. https://doi.org/10.1111/j.1398-9995.2008.01827.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.